RNA Processing: Wilms' tumour — the splicing connection?  by Lamond, Angus I.
ANGUS I. LAMOND RNA PROCESSING
Wilms' tumour - the splicing connection?
Major isoforms of WT1 - products of the tumour suppressor gene WT1,
implicated in predisposition to Wilms' tumour - may preferentially
interact with splicing factors, suggesting a role for WT1 in RNA processing.
Wilms' tumour is one of the most prevalent childhood
malignancies, giving rise to nephroblastomas in approxi-
mately 1 out of 10 000 children (reviewed in [1]). Wilms'
tumour is also frequently associated with congenital uro-
genital abnormalities. The genetic basis of Wilms' tumour
development is complex, and at least three separate genes
are believed to confer predisposition to this form of
malignancy. So far, only one such Wilms'-tumour-predis-
position gene, called WT1, has been characterized. WT1
is a tumour suppressor gene [2] and is implicated in
10-15 % of Wilms' tumours. Mutations in WT1 can also
give rise to syndromes such as Denys-Drash syndrome,
which is characterized by glomerulonephropathy, pseudo-
hermaphroditism and Wilms' tumour.
The human WT1 gene was mapped to chromosome
1 lp13 and has been cloned and sequenced [3,4]. Analysis
of null mutant mice shows WT1 is essential for both uro-
genital development and fetal survival beyond 15 days of
gestation. 1WT1 mRNA and protein are expressed in spe-
cific cell types at three different stages of nephrogenesis
and also in certain cell types of other mesoderm-derived
tissues, including the gonad, spleen and the mesothelium.
At the same time as these tissues express WT1, they
undergo a switch from mesenchymal to epithelial cell
types. Wilms' tumour thus provides a clear example of
how oncogenesis can arise through a genetic failure in
developmental regulation.
The deduced WT1 protein sequence indicates that it may
act as a DNA-binding factor. It has four carboxy-terminal
Kriippel-type zinc-finger domains and a proline/gluta-
mine-rich transregulatory domain akin to that found in
many known transcriptional regulators (Fig. 1). Zinc fin-
ger motifs 2-4 of WT1 are closely related to the three zinc
fingers of the transcription factors SP1, EGRI and EGR2.
In view of these features of its sequence, it has been widely
believed that the WT1 protein acts to regulate transcrip-
tion of genes required for normal kidney development.
Although no genes regulated by WT1 in vivo have yet
been identified, WT1 is known to bind in vitro to the
DNA sequence 5'-GCGGGGGCG-3' [5]. This is the
consensus binding site for EGR1, and occurs in the pro-
moter region of many genes, including some that are
implicated in growth regulation. Data from transient
transfection assays indicate that WT1 can repress tran-
scription from promoters containing the EGR1 consensus
binding site [1]. Clinical studies have shown that many
patients suffering from Denys-Drash syndrome and
Wilms' tumour have point mutations or deletions in the
zinc-finger regions of WT1 and, in at least some cases,
these mutations have been found to affect DNA binding.
Four isoforms of WT1 are formed by alternative RNA
splicing (Fig. 1). These arise from the inclusion or omis-
sion of the 17 amino acids encoded by exon 5, amino ter-
minal to the first zinc finger, and the inclusion or omis-
sion of the three amino acids lysine-threonine-serine
(KTS) between zinc fingers 3 and 4. The insertion of
KTS arises through use of an alternative 5' splice site at
the end of exon 9. The +KTS isoforms are some four-
fold more abundant than the -KTS isoforms. Compara-
tive sequence analysis has shown that WT1 is highly con-
served among vertebrates; although the alternative splicing
of exon 5 has only been detected in mammals, the alter-
native splicing of KTS between zinc fingers 3 and 4 is
conserved from zebrafish to humans. This strongly indi-
cates that the insertion of KTS is functionally important.
Interestingly, inclusion of KTS between zinc fingers 3 and
4 has been found to change the DNA-binding properties
of WT1. It is the -KTS isoforms that specifically bind to
the EGR1 consensus sequence, whereas the +KTS iso-
forms do not strongly bind this sequence, and in compar-
ison show a generally reduced affinity for DNA. Patients
with abnormal ratios of the +KTS and -KTS WT1 iso-
forms can also manifest severe developmental problems,
again pointing to the important role of the alternative
splicing of the KTS motif. New data from Hastie and
coworkers [6] now show that alternative splicing of the
KTS motif influences the intranuclear localization of
WT1 - the +KTS isoforms associate with components
of the pre-mRNA splicing machinery.
Fig. 1. WT1 is a protein of -53 kDa which has a proline/gluta-
mine-rich domain in the amino-terminal region and four zinc fin-
ger domains (red) in the carboxy-terminal region. Four isoforms
of WT1 are produced through alternative splicing. This results in
either inclusion or omission of exon 5 and of the three amino
acids lysine-threonine-serine (KTS) between zinc fingers 3 and
4. The isoform shown includes both the exon-5-encoded and
KTS sequences (green).
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Larsson et al. [6] used confocal-fluorescence-microscopy
analysis to localize WT1 in either fetal kidney or gonad
tissue, or in a mesonephric cell line (M15) that expresses
endogenous WT1. These studies were done using both
polyclonal and monoclonal anti-WT1 antibodies and, in
each case, the anti-WT1 antibodies specifically labelled
the nucleus in a characteristic punctate pattern, as well as
giving a more diffuse nucleoplasmic staining, excluding
nucleoli. Double-labelling experiments using antibodies
that recognize other zinc-finger transcription factors,
such as SP1, showed that there is a major difference
between the staining patterns for the two proteins.
Although both antibodies show diffuse nucleoplasmic
labelling and both stain punctate structures, these punc-
tate structures are distinct. In contrast, double labelling
with anti-WT1 and anti-snRNP antibodies showed
extensive co-localization, with both antibodies staining
the same punctate structures, although the diffuse
nucleoplasmic staining was stronger with the anti-WT1
antibodies than with the anti-snRNP antibodies (Fig. 2).
The major subunits of active splicing complexes -
spliceosomes - are the U1, U2, U4/U6 and U5 small
nuclear ribonucleoprotein particles (snRNPs). Splice-
osomes form through the stepwise assembly of snRNPs
and additional non-snRNP protein-splicing factors on
mRNA precursor transcripts, and catalyze the removal of
introns. In vivo, most splicing is believed to occur cotran-
scriptionally. Immunofluorescence localization studies,
using antibodies specific for snRNP antigens, have
revealed a complex snRNP staining pattern that includes
at least three components (reviewed in [7,8]; compare
with Fig. 2).
The first component of the snRNP-staining pattern is a
widespread, diffuse staining that disappears if transcrip-
tion is inhibited. It is likely that this widespread staining
includes the bulk of snRNPs involved in cotranscrip-
tional splicing. Nascent transcripts emerging from chro-
matin can be seen at the electron microscopic (EM)
level as perichromatin fibrils. The other two compo-
nents of the snRNP-staining pattern seen by fluores-
cence microscopy appear as numerous, irregular-shaped
speckles and several bright round foci, forming a charac-
teristic punctate pattern. At the EM level, the speckles
correspond to clusters of interchromatin granules,
whereas the foci correspond to coiled bodies. The new
data from Larsson et al. [6] show that WT1 co-localizes
with snRNPs in both interchromatin granule clusters
and coiled bodies. Neither of these punctate structures
are now believed to be major sites of splicing per se.
The functions of coiled bodies and interchromatin
granules remain to be established, but may include roles
in snRNP maturation and assembly, recycling after
splicing, and RNA transport or storage.
It is known that the snRNP staining pattern is highly
dynamic and is affected by treatments that influence
cellular gene expression. Both the WT1 and snRNP
staining patterns were observed to change following
Fig. 2. Antibodies that recognize either WTI or splicing snRNPs
show a similar punctate staining pattern. This pattern comprises
labelling of coiled bodies (red), clusters of interchromatin gran-
ules (blue) and a diffuse, widespread nucleoplasmic component
that excludes nucleoli (grey). The diffuse component is more
prominent for WT1 than for snRNPs, and most transcription and
splicing takes place over this region. As discussed in the text,
both WT1 and snRNP staining patterns change if gene expression
is inhibited.
microinjection of M15 cells with DNA oligonu-
cleotides that were complementary to either the U1 or
U6 snRNAs [6]. These oligonucleotides promote cleav-
age of the complementary snRNAs by endogenous
RNaseH, and hence inhibit splicing. It has previously
been shown that this results in a redistribution of
snRNP antigens into large nucleoplasmic aggregates [9],
and a similar redistribution of WT1 has now been
observed [6].
It has been shown previously that inhibition of transcrip-
tion by actinomycin D results in a loss of the diffuse
snRNP staining, and loss of coiled bodies, with a con-
comitant clustering of most snRNP antigens into large
nucleoplasmic aggregates of interchromatin granules. In
addition, the coiled body protein, p80 coilin, and a sub-
set of snRNP antigens form smaller foci that cluster
around the periphery of the nucleolus and nucleolar
remnants [10]. Double-labelling studies in M15 cells
showed that WT1 specifically relocalized into the same
perinucleolar structures that contain p80 coilin, but not
into the nucleoplasmic snRNP clusters, following treat-
ment with actinomycin D [6]. Together, these data con-
firm the in vivo association of WT1 with structures con-
taining splicing snRNPs, and further indicate that WT1
can preferentially localize with a complex containing p80
coilin and a subset of splicing components following
actinomycin D treatment.
The association of WT1 with splicing snRNPs was also
confirmed biochemically using coimmunoprecipitation
assays with nuclear extracts prepared from M15 cells. Anti-
bodies specific for the common (Sm-type) snRNP anti-
gens, and antibodies specific for proteins unique to either
the Ul or U2 snRNP particles, all coimmunoprecipitated
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WT1. Interestingly, WT1 was also coimmunoprecipi-
tated by antibodies specific for the coiled-body protein,
p80 coilin. These antibodies selectively stain coiled bod-
ies, but not interchromatin granule clusters, when used
for immunofluorescence. An antibody specific for the
transcription factor SP1 did not coprecipitate WT1.
When the immunoprecipitation assays were repeated
using nuclear extracts prepared from M15 cells that were
treated with actinomycin D, WT1 was still coimmuno-
precipitated by anti-p80 coilin antibodies, but not by
anti-Sm antibodies. In parallel controls, actinomycin D
did not prevent direct immunoprecipitation of WT1 by
anti-WT1 antibodies and did not result in coimmuno-
precipitation of WT1 by anti-SP1 antibodies. Although
these studies do not provide a quantitative measure of
the extent of interaction between WT1 and splicing
snRNPs, they correlate very closely with the immuno-
fluorescence data. These findings indicate that WT1 is
present in a common complex with splicing snRNPs
and are consistent with WT1 interacting directly with
snRNPs. The results also point to an interaction between
WT1 and the coiled-body protein, p8 0 coilin, which
remains even when transcription is blocked by actino-
mycin D treatment.
As indicated above, the DNA-binding activity of WT1
was known to differ between isoforms that either have,
or lack, the KTS insertion between zinc fingers 3 and 4.
To address whether the four separate WT1 isoforms have
similar, or different, nuclear localization patterns, Larsson
et al. [6] examined each isoform individually by transient
transfection in COS7 cells, which do not express endo-
genous WT1. These experiments showed that the local-
ization was largely (but not completely) splice-form
dependent. More specifically, there was a strong correla-
tion between expression of isoforms that contained the
KTS insert and co-localization with snRNPs. In con-
trast, preferential co-localization with snRNPs was not
influenced by the presence or absence of the alternatively
spliced exon 5.
Transient expression of genes encoding either the SP1 or
PAX6 transcription factors in COS7 cells showed that
both these proteins also localized to punctate subnuclear
domains, but these domains did not co-localize with
snRNPs and were labelled strongly by antibodies that
recognize the endogenous basal transcription factor
TFIIB. Interestingly, these SP1/PAX6 domains showed a
preferential co-localization with the WT1 isoforms lack-
ing the KTS insert, which in turn show less frequent
overlap with snRNP-containing structures.
The localization data, while complicated in detail, point
to a rather simple general conclusion: the presence or
absence of the KTS insert between zinc fingers 3 and 4
of WT1 not only influences its affinity for binding DNA,
but also has a dramatic effect upon the distribution of
WT1 within the nucleus. Thus, the distribution of WT1
in tissues is likely to represent a composite of several
distinct labelling patterns, in which the separate isoforms
distribute differentially. This provides a clear example of
how alternative splicing can modulate intranuclear pro-
tein localization. The fact that the most abundant iso-
forms of WT1 preferentially localize to subnuclear
domains containing splicing snRNPs suggests that the
view that it is primarily a transcription factor may have
to be revised. Instead, a role for WT1 in either splicing,
or some other aspect of RNA metabolism, appears a
strong possibility.
As is usual with interesting discoveries, the new data on
WT1 raise many more questions than they answer. For
example, does WT1 have dual roles in transcription and
RNA processing, mediated by separate isoforms? There
are precedents for proteins, such as TFIIIA, that can bind
in vivo to both DNA and RNA through a zinc finger
motif. The differential distribution of WT1 isoforms may
have profound significance for understanding the under-
lying causes of developmental abnormalities that can arise
in patients with altered ratios of +KTS and -KTS iso-
forms. This could be due, at least in part, to an imbalance
in the distribution of WT1 between splicing and tran-
scription domains. It is possible, however, that the subset
of WT1 associated with transcription domains could be
involved in cotranscriptional splicing, rather than DNA
binding and transcription. In this case the primary role of
WT1 could be connected with splicing snRNPs. A
detailed study of the RNA binding activity of WT1 iso-
forms will now be important. It will also be important to
establish whether WT1 interacts directly with snRNP
particles and whether it is present in active spliceosomes.
The WT1 protein is clearly not an obligatory splicing
factor, as it is only expressed in restricted cell types.
However, it could well have a function in regulating
splicing in these cells and this needs to be addressed bio-
chemically. The reason for the association of WT1 with
coiled bodies and with the coiled-body protein, p80
coilin, even when snRNPs have dissociated from the
coiled body following inhibition of transcription, pre-
sents another interesting line of investigation. The coiled
body is a conserved snRNP domain found in both plant
and animal cells, but its function remains unknown
(reviewed in [8]). Future studies on WT1 could offer
some clues as to the role of the coiled body and will
hopefully clarify whether the tumour suppressor activity
of WT1 is exerted at the post-transcriptional level. If this
is the case, we may look forward to important new
insights into the role of RNA processing mechanisms in
cellular growth control and oncogenesis.
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